檢索結果 - M. Barbolini
- Showing 1 - 2 results of 2
-
1
-
2
P120 Cardiac safety of pertuzumab, trastuzumab and standard chemotherapy as neoadjuvant treatment for HER2 positive breast cancer: real world data from NeoPowER trial 由 F. Canino, M. Barbolini, U. De Giorgi, M. Dominici, L. Gianni, L. Moscetti, C. Omarini, C. Zamagni, A. Molinaro, G. Antonelli, F. Baglio, G. Martinelli, S. Natalizio, O. Ponzoni, F. Piacentini
發表在 Breast (2023-03-01)獲取全文
Article
